Voya Investment Management LLC Gilead Sciences, Inc. Transaction History

Voya Investment Management LLC

$86.1 Billion
Q1 2024

A detailed history of Voya Investment Management LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 1,082,535 shares of GILD stock, worth $74.3 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,082,535

Previous 1,114,959 2.91%

Holding current value

$74.3 Million

Previous $90.3 Million 12.21%

% of portfolio

0.09%

Previous 0.11%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$71.58 - $87.29 $2.32 Million - $2.83 Million	-32,424 Reduced 2.91%	1,082,535 $79.3 Million
Q4 2023 Feb 14, 2024	SELL	$73.27 - $83.09 $2.04 Million - $2.32 Million	-27,909 Reduced 2.44%	1,114,959 $90.3 Million
Q3 2023 Nov 14, 2023	BUY	$73.94 - $80.67 $441,865 - $482,083	5,976 Added 0.53%	1,142,868 $85.6 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $32,076 - $36,587	-422 Reduced 0.04%	1,136,892 $87.6 Million
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $7.68 Million - $8.76 Million	-99,399 Reduced 8.04%	1,137,314 $94.4 Million

Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $11.7 Million - $16.8 Million	-187,404 Reduced 13.16%	1,236,713 $106 Million
Q3 2022 Mar 03, 2023	BUY	$59.54 - $68.01 $11.2 Million - $12.7 Million	187,404 Added 15.15%	1,424,117 $87.9 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $24.8 Million - $28.3 Million	416,131 Added 41.28%	1,424,117 $87.9 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $5.48 Million - $6.18 Million	95,002 Added 10.41%	1,007,986 $62.3 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $1.34 Million - $1.68 Million	23,096 Added 2.6%	912,984 $54.3 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $7.72 Million - $8.76 Million	118,938 Added 15.43%	889,888 $64.6 Million
Q3 2021 Nov 15, 2021	SELL	$67.69 - $73.03 $1.58 Million - $1.7 Million	-23,336 Reduced 2.94%	770,950 $53.9 Million
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $1.02 Million - $1.11 Million	-16,032 Reduced 1.98%	794,286 $54.7 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $2.07 Million - $2.36 Million	-34,451 Reduced 4.08%	810,318 $52.4 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $1.08 Million - $1.23 Million	19,041 Added 2.31%	844,769 $49.2 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $1.37 Million - $1.72 Million	21,981 Added 2.73%	825,728 $52.2 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $4.99 Million - $5.79 Million	-68,953 Reduced 7.9%	803,747 $61.8 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $54.5 Million - $69.8 Million	-869,892 Reduced 49.92%	872,700 $65.2 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $42.8 Million - $47 Million	-694,148 Reduced 28.49%	1,742,592 $113 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $34.8 Million - $38.4 Million	556,936 Added 29.63%	2,436,740 $154 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $16.7 Million - $18.7 Million	269,877 Added 16.76%	1,879,804 $127 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $16 Million - $17.9 Million	-255,358 Reduced 13.69%	1,609,927 $105 Million
Q4 2018 Feb 14, 2019	SELL	$60.54 - $79.0 $4.63 Million - $6.05 Million	-76,548 Reduced 3.94%	1,865,285 $117 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $2.04 Million - $2.26 Million	-28,635 Reduced 1.45%	1,941,833 $150 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $8.53 Million - $9.95 Million	131,521 Added 7.15%	1,970,468 $140 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $126 Million - $154 Million	-1,729,113 Reduced 48.46%	1,838,947 $139 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $2.44 Million - $2.86 Million	34,262 Added 0.97%	3,568,060 $256 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $255 Million - $302 Million	3,533,798	3,533,798 $286 Million

Others Institutions Holding GILD

# of Institutions

1,884

Shares Held

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $86B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Gilead Sciences, Inc. Transaction History